+

DK1265629T3 - Anvendelse af væksthormon i lav dosis - Google Patents

Anvendelse af væksthormon i lav dosis

Info

Publication number
DK1265629T3
DK1265629T3 DK01914289T DK01914289T DK1265629T3 DK 1265629 T3 DK1265629 T3 DK 1265629T3 DK 01914289 T DK01914289 T DK 01914289T DK 01914289 T DK01914289 T DK 01914289T DK 1265629 T3 DK1265629 T3 DK 1265629T3
Authority
DK
Denmark
Prior art keywords
growth hormone
less
low dose
day
therapy
Prior art date
Application number
DK01914289T
Other languages
Danish (da)
English (en)
Inventor
David B Dunger
Original Assignee
Pfizer Health Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Health Ab filed Critical Pfizer Health Ab
Application granted granted Critical
Publication of DK1265629T3 publication Critical patent/DK1265629T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK01914289T 2000-03-13 2001-03-13 Anvendelse af væksthormon i lav dosis DK1265629T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0000837A SE0000837D0 (sv) 2000-03-13 2000-03-13 New use

Publications (1)

Publication Number Publication Date
DK1265629T3 true DK1265629T3 (da) 2006-08-28

Family

ID=20278800

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01914289T DK1265629T3 (da) 2000-03-13 2001-03-13 Anvendelse af væksthormon i lav dosis

Country Status (13)

Country Link
US (2) US6696414B2 (fr)
EP (1) EP1265629B1 (fr)
JP (1) JP2003526675A (fr)
AT (1) ATE328604T1 (fr)
AU (1) AU2001239635A1 (fr)
CA (1) CA2402948A1 (fr)
DE (1) DE60120371T2 (fr)
DK (1) DK1265629T3 (fr)
ES (1) ES2263601T3 (fr)
NZ (1) NZ533844A (fr)
PT (1) PT1265629E (fr)
SE (1) SE0000837D0 (fr)
WO (1) WO2001068127A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020165127A1 (en) * 1996-12-24 2002-11-07 Supergen, Inc. Methods for treating insulin resistance and identifying patients at risk for the disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670393A (en) 1982-03-22 1987-06-02 Genentech, Inc. DNA vectors encoding a novel human growth hormone-variant protein
US5079345A (en) * 1988-08-19 1992-01-07 Eli Lilly And Company Proteins having growth hormone anabolic properties with reduced effect on carbohydrate metabolism
DE68929151T2 (de) 1988-10-28 2000-07-20 Genentech, Inc. Verfahren zum nachweis von aktiven domänen und aminosäureresten in polypeptiden und hormonvarianten
EP0441889A1 (fr) 1988-11-07 1991-08-21 Commission des Communautés Européennes Hormone de croissance humaine modifiee
IT1251895B (it) 1991-09-27 1995-05-26 Eniricerche Spa Mutanti dell'ormone della crescita umano e loro impiego
AU675996B2 (en) 1992-10-29 1997-02-27 Genentech Inc. Method for treatment or prevention of obesity
US5597709A (en) * 1994-01-27 1997-01-28 Human Genome Sciences, Inc. Human growth hormone splice variants hGHV-2(88) and hGHV-3(53)
EP0766966A3 (fr) 1995-09-08 2001-02-28 Eli Lilly And Company Méthode de traitement de la résistance à l'insuline
SE9601397D0 (sv) * 1996-04-12 1996-04-12 Pharmacia Ab Use of growth hormone
ATE209042T1 (de) 1997-07-04 2001-12-15 Pharmacia Ab Verwendung des wachstumshormons in mitteln zur behandlung der insulinresistenz im herzen

Also Published As

Publication number Publication date
US6696414B2 (en) 2004-02-24
PT1265629E (pt) 2006-09-29
ES2263601T3 (es) 2006-12-16
AU2001239635A1 (en) 2001-09-24
DE60120371T2 (de) 2007-05-16
EP1265629B1 (fr) 2006-06-07
NZ533844A (en) 2007-11-30
WO2001068127A1 (fr) 2001-09-20
CA2402948A1 (fr) 2001-09-20
US20040147446A1 (en) 2004-07-29
US7229965B2 (en) 2007-06-12
DE60120371D1 (de) 2006-07-20
ATE328604T1 (de) 2006-06-15
EP1265629A1 (fr) 2002-12-18
SE0000837D0 (sv) 2000-03-13
US20010051601A1 (en) 2001-12-13
JP2003526675A (ja) 2003-09-09

Similar Documents

Publication Publication Date Title
TR200001891T2 (tr) ASPB28- İnsan ensülini ve kullanımı.
BRPI0015284B8 (pt) formulações de hidrocodona de liberação controlada
NO20014519L (no) Apomorfin- og sildenafilpreparat
ATE515265T1 (de) Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen
JP2006514092A5 (fr)
SG146638A1 (en) Pharmaceutical delivery system
BG104797A (en) Use of dexmedetomi dine for sedative effect in patients in an intensive care unit
CO5251425A1 (es) Metodo y composiciones para administrar taxanos oralmente a pacientes humanos
JP2002540148A5 (fr)
BR0009380A (pt) Tratamento de câncer melhorado comtemozolomida
CA2450915A1 (fr) Utilisation de levosimendane et d'un antagoniste du recepteur beta-adrenergique pour traiter les defaillances cardiaques
IL163091A (en) Medical product and pharmaceutical composition comprising as active ingredients a thrombolytic agent and levosimendan or a pharmaceutically acceptable salt thereof and the use of same in the manufacture of medicament for reducing mortality of patients with acute myocardial infarction
NO20061515L (no) Anvendelse av okskarbazepin for behandling av diabetisk neurpatisk smerte og forbedring av sovn
NZ594154A (en) Transdermal administration of buprenorphine for preoperative treatment of post operative pain
LT2006024A (en) Tetrapeptide regulating blood glucose level in diabetes mellitus
EA200200801A1 (ru) Применение фолликулостимулирующего гормона (fsh) для лечения бесплодия
DK1265629T3 (da) Anvendelse af væksthormon i lav dosis
MXPA02009603A (es) Terapias de dosis divididas con actividad de deterioro vascular.
TWI263502B (en) Pharmaceutical preparation for treating ischemic disease of heart or limbs
RU94000695A (ru) Средство с противоаллергическим действием
AR109456A2 (es) Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación
MD1568G2 (ro) Metodă de tratament al bolii arşilor în perioada şocului combustional
DE10293092D2 (de) Schilddrüsentherapeutika
MD1610G2 (ro) Metodă de tratament al stomatitei aftoase recidivante cronice
Yu Biventricular Pacing Therapy for Heart Failure
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载